You searched for "simulator"
Detection of post stroke visual impairment in variety of cohorts
The Impact of Visual Impairment after Stroke (IVIS) study introduced a standardised vision assessment protocol across three acute stroke units in the northwest of England, with a similar demographic population (predominantly white British). The study reported similar rates of visual...
Outcomes for strabismus surgery dependent on access to insurance
The primary aim of this study was to compare postoperative outcomes in a larger cohort of paediatric patients having strabismus surgery with at least 11 months follow-up to determine the impact of low socio-economic status (SES) and health disparities and...Exeter clinic manager wins VCHP Volunteer Award
Exeter VCHP clinic manager, Zoe Haigh, has been recognised for her outstanding contribution to the charity during the past six years.Optical Suppliers Association: Autumn Meeting set for 27 October
The OSA’s Autumn Meeting will take place on 27 October at the St Pancras Hotel in London, providing member companies with the chance to learn more about organising their own CPD sessions. Looking ahead to 100% Optical and other opportunities...3rd Annual Retinal Imaging Biomarkers & Endpoints Summit
Accelerate Your Ophthalmic Development with Deep Learning Systems & Sophisticated AI Imaging TechnologiesWith state-of-the-art AI-assisted technology making retinal imaging 100 times faster, the rapid advancement of technology in ophthalmology, coupled with the strong unmet need for more drugs for retinal...
The effect of everolimus on retinal pigment epithelium and proliferative vitreo-retinopathy
The principal cells involved in proliferative vitreo-retinopathy (PVR) are retinal pigment epithelial cells (RPE). Everolimus is a drug used in renal cell carcinoma which targets and inhibits a key regulatory protein in cancer (mTOR). In this study, the authors investigated...
How the thinking machine is transforming the retinal landscape
Regulatory approval of the first two therapeutic substances for the management of geographic atrophy (GA) secondary to age-related macular degeneration has been a major breakthrough. The authors explored the issue surrounding the lack of agreed therapeutic standards and diagnostic tools...
